Global Cell and Gene Therapy Supply Chain and Logistics Supply, Demand and Key Producers, 2023-2029
The global Cell and Gene Therapy Supply Chain and Logistics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Cell and Gene Therapy Supply Chain and Logistics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Supply Chain and Logistics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Supply Chain and Logistics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy Supply Chain and Logistics total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Supply Chain and Logistics total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market By Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Clarkston Consulting and Hypertrust Patient Data Care, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Supply Chain and Logistics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and By Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell and Gene Therapy Supply Chain and Logistics Market, By Region:
1. How big is the global Cell and Gene Therapy Supply Chain and Logistics market?
2. What is the demand of the global Cell and Gene Therapy Supply Chain and Logistics market?
3. What is the year over year growth of the global Cell and Gene Therapy Supply Chain and Logistics market?
4. What is the total value of the global Cell and Gene Therapy Supply Chain and Logistics market?
5. Who are the major players in the global Cell and Gene Therapy Supply Chain and Logistics market?
6. What are the growth factors driving the market demand?
This report studies the global Cell and Gene Therapy Supply Chain and Logistics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Supply Chain and Logistics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Supply Chain and Logistics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy Supply Chain and Logistics total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy Supply Chain and Logistics total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy Supply Chain and Logistics total market By Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cell and Gene Therapy Supply Chain and Logistics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Clarkston Consulting and Hypertrust Patient Data Care, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Supply Chain and Logistics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and By Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell and Gene Therapy Supply Chain and Logistics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Ordering and Scheduling Services
- Sample Collection Services
- Logistics Services
- Post Treatment Follow-Up Services
- Biobank
- Cell Therapy Lab
- Hospital
- Research Institute
- Be The Match BioTherapies
- Biocair
- Marken
- World Courier
- MAK-SYSTEM
- Cryoport
- Brooks Life Sciences
- Clarkston Consulting
- Hypertrust Patient Data Care
- Haemonetics
- MasterControl
- TraceLink
- SAVSU Technologies
- TrakCel
- Title21 Health Solutions
- sedApta Group
- Vineti
- Stafa Cellular Therapy
- Thermo Fisher Scientific
- McKesson
- BioLife Solutions
1. How big is the global Cell and Gene Therapy Supply Chain and Logistics market?
2. What is the demand of the global Cell and Gene Therapy Supply Chain and Logistics market?
3. What is the year over year growth of the global Cell and Gene Therapy Supply Chain and Logistics market?
4. What is the total value of the global Cell and Gene Therapy Supply Chain and Logistics market?
5. Who are the major players in the global Cell and Gene Therapy Supply Chain and Logistics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cell and Gene Therapy Supply Chain and Logistics Introduction
1.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy Supply Chain and Logistics Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.3 China Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.5 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.6 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.7 ASEAN Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.8 India Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell and Gene Therapy Supply Chain and Logistics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region
2.2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023)
2.2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
3 WORLD CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics in 2022
3.3 Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
3.4 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.4.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2018-2023
4.3.1 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue and Market Share, 2018-2023
4.4.1 China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Ordering and Scheduling Services
5.2.2 Sample Collection Services
5.2.3 Logistics Services
5.2.4 Post Treatment Follow-Up Services
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2018-2023)
5.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2024-2029)
5.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview By Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction By Application
6.2.1 Biobank
6.2.2 Cell Therapy Lab
6.2.3 Hospital
6.2.4 Research Institute
6.2.5 Research Institute
6.3 Market Segment By Application
6.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2023)
6.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2024-2029)
6.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2029)
7 COMPANY PROFILES
7.1 Be The Match BioTherapies
7.1.1 Be The Match BioTherapies Details
7.1.2 Be The Match BioTherapies Major Business
7.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Be The Match BioTherapies Recent Developments/Updates
7.1.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
7.2 Biocair
7.2.1 Biocair Details
7.2.2 Biocair Major Business
7.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Biocair Recent Developments/Updates
7.2.6 Biocair Competitive Strengths & Weaknesses
7.3 Marken
7.3.1 Marken Details
7.3.2 Marken Major Business
7.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Marken Recent Developments/Updates
7.3.6 Marken Competitive Strengths & Weaknesses
7.4 World Courier
7.4.1 World Courier Details
7.4.2 World Courier Major Business
7.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 World Courier Recent Developments/Updates
7.4.6 World Courier Competitive Strengths & Weaknesses
7.5 MAK-SYSTEM
7.5.1 MAK-SYSTEM Details
7.5.2 MAK-SYSTEM Major Business
7.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 MAK-SYSTEM Recent Developments/Updates
7.5.6 MAK-SYSTEM Competitive Strengths & Weaknesses
7.6 Cryoport
7.6.1 Cryoport Details
7.6.2 Cryoport Major Business
7.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Cryoport Recent Developments/Updates
7.6.6 Cryoport Competitive Strengths & Weaknesses
7.7 Brooks Life Sciences
7.7.1 Brooks Life Sciences Details
7.7.2 Brooks Life Sciences Major Business
7.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Brooks Life Sciences Recent Developments/Updates
7.7.6 Brooks Life Sciences Competitive Strengths & Weaknesses
7.8 Clarkston Consulting
7.8.1 Clarkston Consulting Details
7.8.2 Clarkston Consulting Major Business
7.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Clarkston Consulting Recent Developments/Updates
7.8.6 Clarkston Consulting Competitive Strengths & Weaknesses
7.9 Hypertrust Patient Data Care
7.9.1 Hypertrust Patient Data Care Details
7.9.2 Hypertrust Patient Data Care Major Business
7.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Hypertrust Patient Data Care Recent Developments/Updates
7.9.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
7.10 Haemonetics
7.10.1 Haemonetics Details
7.10.2 Haemonetics Major Business
7.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Haemonetics Recent Developments/Updates
7.10.6 Haemonetics Competitive Strengths & Weaknesses
7.11 MasterControl
7.11.1 MasterControl Details
7.11.2 MasterControl Major Business
7.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 MasterControl Recent Developments/Updates
7.11.6 MasterControl Competitive Strengths & Weaknesses
7.12 TraceLink
7.12.1 TraceLink Details
7.12.2 TraceLink Major Business
7.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 TraceLink Recent Developments/Updates
7.12.6 TraceLink Competitive Strengths & Weaknesses
7.13 SAVSU Technologies
7.13.1 SAVSU Technologies Details
7.13.2 SAVSU Technologies Major Business
7.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 SAVSU Technologies Recent Developments/Updates
7.13.6 SAVSU Technologies Competitive Strengths & Weaknesses
7.14 TrakCel
7.14.1 TrakCel Details
7.14.2 TrakCel Major Business
7.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 TrakCel Recent Developments/Updates
7.14.6 TrakCel Competitive Strengths & Weaknesses
7.15 Title21 Health Solutions
7.15.1 Title21 Health Solutions Details
7.15.2 Title21 Health Solutions Major Business
7.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Title21 Health Solutions Recent Developments/Updates
7.15.6 Title21 Health Solutions Competitive Strengths & Weaknesses
7.16 sedApta Group
7.16.1 sedApta Group Details
7.16.2 sedApta Group Major Business
7.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 sedApta Group Recent Developments/Updates
7.16.6 sedApta Group Competitive Strengths & Weaknesses
7.17 Vineti
7.17.1 Vineti Details
7.17.2 Vineti Major Business
7.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Vineti Recent Developments/Updates
7.17.6 Vineti Competitive Strengths & Weaknesses
7.18 Stafa Cellular Therapy
7.18.1 Stafa Cellular Therapy Details
7.18.2 Stafa Cellular Therapy Major Business
7.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Stafa Cellular Therapy Recent Developments/Updates
7.18.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Details
7.19.2 Thermo Fisher Scientific Major Business
7.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Thermo Fisher Scientific Recent Developments/Updates
7.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.20 McKesson
7.20.1 McKesson Details
7.20.2 McKesson Major Business
7.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 McKesson Recent Developments/Updates
7.20.6 McKesson Competitive Strengths & Weaknesses
7.21 BioLife Solutions
7.21.1 BioLife Solutions Details
7.21.2 BioLife Solutions Major Business
7.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 BioLife Solutions Recent Developments/Updates
7.21.6 BioLife Solutions Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
8.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
8.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
8.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell and Gene Therapy Supply Chain and Logistics Introduction
1.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy Supply Chain and Logistics Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.3 China Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.5 Japan Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.6 South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.7 ASEAN Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.3.8 India Cell and Gene Therapy Supply Chain and Logistics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy Supply Chain and Logistics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell and Gene Therapy Supply Chain and Logistics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region
2.2.1 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023)
2.2.2 World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029)
3 WORLD CELL AND GENE THERAPY SUPPLY CHAIN AND LOGISTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics in 2022
3.3 Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
3.4 Cell and Gene Therapy Supply Chain and Logistics Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy Supply Chain and Logistics Market: Region Footprint
3.4.2 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2018-2023
4.3.1 United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue and Market Share, 2018-2023
4.4.1 China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Ordering and Scheduling Services
5.2.2 Sample Collection Services
5.2.3 Logistics Services
5.2.4 Post Treatment Follow-Up Services
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2018-2023)
5.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2024-2029)
5.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size Overview By Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction By Application
6.2.1 Biobank
6.2.2 Cell Therapy Lab
6.2.3 Hospital
6.2.4 Research Institute
6.2.5 Research Institute
6.3 Market Segment By Application
6.3.1 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2023)
6.3.2 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2024-2029)
6.3.3 World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2029)
7 COMPANY PROFILES
7.1 Be The Match BioTherapies
7.1.1 Be The Match BioTherapies Details
7.1.2 Be The Match BioTherapies Major Business
7.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Be The Match BioTherapies Recent Developments/Updates
7.1.6 Be The Match BioTherapies Competitive Strengths & Weaknesses
7.2 Biocair
7.2.1 Biocair Details
7.2.2 Biocair Major Business
7.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Biocair Recent Developments/Updates
7.2.6 Biocair Competitive Strengths & Weaknesses
7.3 Marken
7.3.1 Marken Details
7.3.2 Marken Major Business
7.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Marken Recent Developments/Updates
7.3.6 Marken Competitive Strengths & Weaknesses
7.4 World Courier
7.4.1 World Courier Details
7.4.2 World Courier Major Business
7.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 World Courier Recent Developments/Updates
7.4.6 World Courier Competitive Strengths & Weaknesses
7.5 MAK-SYSTEM
7.5.1 MAK-SYSTEM Details
7.5.2 MAK-SYSTEM Major Business
7.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 MAK-SYSTEM Recent Developments/Updates
7.5.6 MAK-SYSTEM Competitive Strengths & Weaknesses
7.6 Cryoport
7.6.1 Cryoport Details
7.6.2 Cryoport Major Business
7.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Cryoport Recent Developments/Updates
7.6.6 Cryoport Competitive Strengths & Weaknesses
7.7 Brooks Life Sciences
7.7.1 Brooks Life Sciences Details
7.7.2 Brooks Life Sciences Major Business
7.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Brooks Life Sciences Recent Developments/Updates
7.7.6 Brooks Life Sciences Competitive Strengths & Weaknesses
7.8 Clarkston Consulting
7.8.1 Clarkston Consulting Details
7.8.2 Clarkston Consulting Major Business
7.8.3 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.8.4 Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Clarkston Consulting Recent Developments/Updates
7.8.6 Clarkston Consulting Competitive Strengths & Weaknesses
7.9 Hypertrust Patient Data Care
7.9.1 Hypertrust Patient Data Care Details
7.9.2 Hypertrust Patient Data Care Major Business
7.9.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.9.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Hypertrust Patient Data Care Recent Developments/Updates
7.9.6 Hypertrust Patient Data Care Competitive Strengths & Weaknesses
7.10 Haemonetics
7.10.1 Haemonetics Details
7.10.2 Haemonetics Major Business
7.10.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.10.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Haemonetics Recent Developments/Updates
7.10.6 Haemonetics Competitive Strengths & Weaknesses
7.11 MasterControl
7.11.1 MasterControl Details
7.11.2 MasterControl Major Business
7.11.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.11.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 MasterControl Recent Developments/Updates
7.11.6 MasterControl Competitive Strengths & Weaknesses
7.12 TraceLink
7.12.1 TraceLink Details
7.12.2 TraceLink Major Business
7.12.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.12.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 TraceLink Recent Developments/Updates
7.12.6 TraceLink Competitive Strengths & Weaknesses
7.13 SAVSU Technologies
7.13.1 SAVSU Technologies Details
7.13.2 SAVSU Technologies Major Business
7.13.3 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.13.4 SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 SAVSU Technologies Recent Developments/Updates
7.13.6 SAVSU Technologies Competitive Strengths & Weaknesses
7.14 TrakCel
7.14.1 TrakCel Details
7.14.2 TrakCel Major Business
7.14.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.14.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 TrakCel Recent Developments/Updates
7.14.6 TrakCel Competitive Strengths & Weaknesses
7.15 Title21 Health Solutions
7.15.1 Title21 Health Solutions Details
7.15.2 Title21 Health Solutions Major Business
7.15.3 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.15.4 Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Title21 Health Solutions Recent Developments/Updates
7.15.6 Title21 Health Solutions Competitive Strengths & Weaknesses
7.16 sedApta Group
7.16.1 sedApta Group Details
7.16.2 sedApta Group Major Business
7.16.3 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.16.4 sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 sedApta Group Recent Developments/Updates
7.16.6 sedApta Group Competitive Strengths & Weaknesses
7.17 Vineti
7.17.1 Vineti Details
7.17.2 Vineti Major Business
7.17.3 Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.17.4 Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Vineti Recent Developments/Updates
7.17.6 Vineti Competitive Strengths & Weaknesses
7.18 Stafa Cellular Therapy
7.18.1 Stafa Cellular Therapy Details
7.18.2 Stafa Cellular Therapy Major Business
7.18.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.18.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Stafa Cellular Therapy Recent Developments/Updates
7.18.6 Stafa Cellular Therapy Competitive Strengths & Weaknesses
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Details
7.19.2 Thermo Fisher Scientific Major Business
7.19.3 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.19.4 Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Thermo Fisher Scientific Recent Developments/Updates
7.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.20 McKesson
7.20.1 McKesson Details
7.20.2 McKesson Major Business
7.20.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.20.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 McKesson Recent Developments/Updates
7.20.6 McKesson Competitive Strengths & Weaknesses
7.21 BioLife Solutions
7.21.1 BioLife Solutions Details
7.21.2 BioLife Solutions Major Business
7.21.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
7.21.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023)
7.21.5 BioLife Solutions Recent Developments/Updates
7.21.6 BioLife Solutions Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell and Gene Therapy Supply Chain and Logistics Industry Chain
8.2 Cell and Gene Therapy Supply Chain and Logistics Upstream Analysis
8.3 Cell and Gene Therapy Supply Chain and Logistics Midstream Analysis
8.4 Cell and Gene Therapy Supply Chain and Logistics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Supply Chain and Logistics Players in 2022
Table 12. World Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Player
Table 15. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Supply Chain and Logistics Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2024-2029) & (USD Million)
Table 35. Be The Match BioTherapies Basic Information, Area Served and Competitors
Table 36. Be The Match BioTherapies Major Business
Table 37. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 38. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Be The Match BioTherapies Recent Developments/Updates
Table 40. Be The Match BioTherapies Competitive Strengths & Weaknesses
Table 41. Biocair Basic Information, Area Served and Competitors
Table 42. Biocair Major Business
Table 43. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 44. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Biocair Recent Developments/Updates
Table 46. Biocair Competitive Strengths & Weaknesses
Table 47. Marken Basic Information, Area Served and Competitors
Table 48. Marken Major Business
Table 49. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 50. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Marken Recent Developments/Updates
Table 52. Marken Competitive Strengths & Weaknesses
Table 53. World Courier Basic Information, Area Served and Competitors
Table 54. World Courier Major Business
Table 55. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 56. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. World Courier Recent Developments/Updates
Table 58. World Courier Competitive Strengths & Weaknesses
Table 59. MAK-SYSTEM Basic Information, Area Served and Competitors
Table 60. MAK-SYSTEM Major Business
Table 61. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 62. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. MAK-SYSTEM Recent Developments/Updates
Table 64. MAK-SYSTEM Competitive Strengths & Weaknesses
Table 65. Cryoport Basic Information, Area Served and Competitors
Table 66. Cryoport Major Business
Table 67. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 68. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Cryoport Recent Developments/Updates
Table 70. Cryoport Competitive Strengths & Weaknesses
Table 71. Brooks Life Sciences Basic Information, Area Served and Competitors
Table 72. Brooks Life Sciences Major Business
Table 73. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 74. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Brooks Life Sciences Recent Developments/Updates
Table 76. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 77. Clarkston Consulting Basic Information, Area Served and Competitors
Table 78. Clarkston Consulting Major Business
Table 79. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 80. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Clarkston Consulting Recent Developments/Updates
Table 82. Clarkston Consulting Competitive Strengths & Weaknesses
Table 83. Hypertrust Patient Data Care Basic Information, Area Served and Competitors
Table 84. Hypertrust Patient Data Care Major Business
Table 85. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 86. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Hypertrust Patient Data Care Recent Developments/Updates
Table 88. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
Table 89. Haemonetics Basic Information, Area Served and Competitors
Table 90. Haemonetics Major Business
Table 91. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 92. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Haemonetics Recent Developments/Updates
Table 94. Haemonetics Competitive Strengths & Weaknesses
Table 95. MasterControl Basic Information, Area Served and Competitors
Table 96. MasterControl Major Business
Table 97. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 98. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. MasterControl Recent Developments/Updates
Table 100. MasterControl Competitive Strengths & Weaknesses
Table 101. TraceLink Basic Information, Area Served and Competitors
Table 102. TraceLink Major Business
Table 103. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 104. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. TraceLink Recent Developments/Updates
Table 106. TraceLink Competitive Strengths & Weaknesses
Table 107. SAVSU Technologies Basic Information, Area Served and Competitors
Table 108. SAVSU Technologies Major Business
Table 109. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 110. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. SAVSU Technologies Recent Developments/Updates
Table 112. SAVSU Technologies Competitive Strengths & Weaknesses
Table 113. TrakCel Basic Information, Area Served and Competitors
Table 114. TrakCel Major Business
Table 115. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 116. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. TrakCel Recent Developments/Updates
Table 118. TrakCel Competitive Strengths & Weaknesses
Table 119. Title21 Health Solutions Basic Information, Area Served and Competitors
Table 120. Title21 Health Solutions Major Business
Table 121. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 122. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Title21 Health Solutions Recent Developments/Updates
Table 124. Title21 Health Solutions Competitive Strengths & Weaknesses
Table 125. sedApta Group Basic Information, Area Served and Competitors
Table 126. sedApta Group Major Business
Table 127. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 128. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. sedApta Group Recent Developments/Updates
Table 130. sedApta Group Competitive Strengths & Weaknesses
Table 131. Vineti Basic Information, Area Served and Competitors
Table 132. Vineti Major Business
Table 133. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 134. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Vineti Recent Developments/Updates
Table 136. Vineti Competitive Strengths & Weaknesses
Table 137. Stafa Cellular Therapy Basic Information, Area Served and Competitors
Table 138. Stafa Cellular Therapy Major Business
Table 139. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 140. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Stafa Cellular Therapy Recent Developments/Updates
Table 142. Stafa Cellular Therapy Competitive Strengths & Weaknesses
Table 143. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 144. Thermo Fisher Scientific Major Business
Table 145. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 146. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Thermo Fisher Scientific Recent Developments/Updates
Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 149. McKesson Basic Information, Area Served and Competitors
Table 150. McKesson Major Business
Table 151. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 152. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. McKesson Recent Developments/Updates
Table 154. BioLife Solutions Basic Information, Area Served and Competitors
Table 155. BioLife Solutions Major Business
Table 156. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 157. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
Table 159. Cell and Gene Therapy Supply Chain and Logistics Typical Customers
Table 1. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy Supply Chain and Logistics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy Supply Chain and Logistics Players in 2022
Table 12. World Cell and Gene Therapy Supply Chain and Logistics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy Supply Chain and Logistics Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy Supply Chain and Logistics Player
Table 15. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy Supply Chain and Logistics Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy Supply Chain and Logistics Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy Supply Chain and Logistics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy Supply Chain and Logistics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy Supply Chain and Logistics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application (2024-2029) & (USD Million)
Table 35. Be The Match BioTherapies Basic Information, Area Served and Competitors
Table 36. Be The Match BioTherapies Major Business
Table 37. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 38. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Be The Match BioTherapies Recent Developments/Updates
Table 40. Be The Match BioTherapies Competitive Strengths & Weaknesses
Table 41. Biocair Basic Information, Area Served and Competitors
Table 42. Biocair Major Business
Table 43. Biocair Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 44. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Biocair Recent Developments/Updates
Table 46. Biocair Competitive Strengths & Weaknesses
Table 47. Marken Basic Information, Area Served and Competitors
Table 48. Marken Major Business
Table 49. Marken Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 50. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Marken Recent Developments/Updates
Table 52. Marken Competitive Strengths & Weaknesses
Table 53. World Courier Basic Information, Area Served and Competitors
Table 54. World Courier Major Business
Table 55. World Courier Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 56. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. World Courier Recent Developments/Updates
Table 58. World Courier Competitive Strengths & Weaknesses
Table 59. MAK-SYSTEM Basic Information, Area Served and Competitors
Table 60. MAK-SYSTEM Major Business
Table 61. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 62. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. MAK-SYSTEM Recent Developments/Updates
Table 64. MAK-SYSTEM Competitive Strengths & Weaknesses
Table 65. Cryoport Basic Information, Area Served and Competitors
Table 66. Cryoport Major Business
Table 67. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 68. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Cryoport Recent Developments/Updates
Table 70. Cryoport Competitive Strengths & Weaknesses
Table 71. Brooks Life Sciences Basic Information, Area Served and Competitors
Table 72. Brooks Life Sciences Major Business
Table 73. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 74. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Brooks Life Sciences Recent Developments/Updates
Table 76. Brooks Life Sciences Competitive Strengths & Weaknesses
Table 77. Clarkston Consulting Basic Information, Area Served and Competitors
Table 78. Clarkston Consulting Major Business
Table 79. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 80. Clarkston Consulting Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Clarkston Consulting Recent Developments/Updates
Table 82. Clarkston Consulting Competitive Strengths & Weaknesses
Table 83. Hypertrust Patient Data Care Basic Information, Area Served and Competitors
Table 84. Hypertrust Patient Data Care Major Business
Table 85. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 86. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Hypertrust Patient Data Care Recent Developments/Updates
Table 88. Hypertrust Patient Data Care Competitive Strengths & Weaknesses
Table 89. Haemonetics Basic Information, Area Served and Competitors
Table 90. Haemonetics Major Business
Table 91. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 92. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Haemonetics Recent Developments/Updates
Table 94. Haemonetics Competitive Strengths & Weaknesses
Table 95. MasterControl Basic Information, Area Served and Competitors
Table 96. MasterControl Major Business
Table 97. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 98. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. MasterControl Recent Developments/Updates
Table 100. MasterControl Competitive Strengths & Weaknesses
Table 101. TraceLink Basic Information, Area Served and Competitors
Table 102. TraceLink Major Business
Table 103. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 104. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. TraceLink Recent Developments/Updates
Table 106. TraceLink Competitive Strengths & Weaknesses
Table 107. SAVSU Technologies Basic Information, Area Served and Competitors
Table 108. SAVSU Technologies Major Business
Table 109. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 110. SAVSU Technologies Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. SAVSU Technologies Recent Developments/Updates
Table 112. SAVSU Technologies Competitive Strengths & Weaknesses
Table 113. TrakCel Basic Information, Area Served and Competitors
Table 114. TrakCel Major Business
Table 115. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 116. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. TrakCel Recent Developments/Updates
Table 118. TrakCel Competitive Strengths & Weaknesses
Table 119. Title21 Health Solutions Basic Information, Area Served and Competitors
Table 120. Title21 Health Solutions Major Business
Table 121. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 122. Title21 Health Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Title21 Health Solutions Recent Developments/Updates
Table 124. Title21 Health Solutions Competitive Strengths & Weaknesses
Table 125. sedApta Group Basic Information, Area Served and Competitors
Table 126. sedApta Group Major Business
Table 127. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 128. sedApta Group Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. sedApta Group Recent Developments/Updates
Table 130. sedApta Group Competitive Strengths & Weaknesses
Table 131. Vineti Basic Information, Area Served and Competitors
Table 132. Vineti Major Business
Table 133. Vineti Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 134. Vineti Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Vineti Recent Developments/Updates
Table 136. Vineti Competitive Strengths & Weaknesses
Table 137. Stafa Cellular Therapy Basic Information, Area Served and Competitors
Table 138. Stafa Cellular Therapy Major Business
Table 139. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 140. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Stafa Cellular Therapy Recent Developments/Updates
Table 142. Stafa Cellular Therapy Competitive Strengths & Weaknesses
Table 143. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 144. Thermo Fisher Scientific Major Business
Table 145. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 146. Thermo Fisher Scientific Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Thermo Fisher Scientific Recent Developments/Updates
Table 148. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 149. McKesson Basic Information, Area Served and Competitors
Table 150. McKesson Major Business
Table 151. McKesson Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 152. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 153. McKesson Recent Developments/Updates
Table 154. BioLife Solutions Basic Information, Area Served and Competitors
Table 155. BioLife Solutions Major Business
Table 156. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product and Services
Table 157. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 158. Global Key Players of Cell and Gene Therapy Supply Chain and Logistics Upstream (Raw Materials)
Table 159. Cell and Gene Therapy Supply Chain and Logistics Typical Customers
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. World Cell and Gene Therapy Supply Chain and Logistics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy Supply Chain and Logistics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type in 2022
Figure 31. Ordering and Scheduling Services
Figure 32. Sample Collection Services
Figure 33. Logistics Services
Figure 34. Post Treatment Follow-Up Services
Figure 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2018-2029)
Figure 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share By Application in 2022
Figure 38. Biobank
Figure 39. Cell Therapy Lab
Figure 40. Hospital
Figure 41. Research Institute
Figure 42. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Cell and Gene Therapy Supply Chain and Logistics Picture
Figure 2. World Cell and Gene Therapy Supply Chain and Logistics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy Supply Chain and Logistics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy Supply Chain and Logistics Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy Supply Chain and Logistics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy Supply Chain and Logistics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy Supply Chain and Logistics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Supply Chain and Logistics Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy Supply Chain and Logistics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy Supply Chain and Logistics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type in 2022
Figure 31. Ordering and Scheduling Services
Figure 32. Sample Collection Services
Figure 33. Logistics Services
Figure 34. Post Treatment Follow-Up Services
Figure 35. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share by Type (2018-2029)
Figure 36. World Cell and Gene Therapy Supply Chain and Logistics Market Size By Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Cell and Gene Therapy Supply Chain and Logistics Market Size Market Share By Application in 2022
Figure 38. Biobank
Figure 39. Cell Therapy Lab
Figure 40. Hospital
Figure 41. Research Institute
Figure 42. Cell and Gene Therapy Supply Chain and Logistics Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
